Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Exploring the Future of Finance with Hanwha Life CEO | Kim Dong Kwan - CEO of Hanwha Corp
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Kim Dong Kwan is the CEO of Hanwha Corp
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Global Investment Strategy in Diverse Asset Classes| Bruce Flatt, CEO,Brookfield Asset Management.
00:10:00
Exploring Lithium and Gold: Simon Discusses Company Strategy at One-to-One Mining Conference
00:10:00
Exploring Innovative ETF Opportunities with John Porter | John Porter, CIO , Newton Investment Management .
00:10:00
Amit Dror, CEO & Co-Founder of Nano Dimension Ltd., spoke with SNNLive at the LD Micro Invitational 2016 in Bel Air, CA.|Yoav Stern, CEO of Nano Dimension
00:10:00
"Empowering Africa: Advancing the Rule of Law" | HON. ANN CLAIREWILLIAMS (RET.) Of Counsel , Lawyer , Jones Day
00:10:00
Closing the Digital Divide with 5G | Marc Ganzi , CEO ,DigitalBridge Group Inc.
00:10:00
Nir Bar Dea Announces Bridgewater's Partnership for Côte d'Ivoire Economic Summit at Global Citizen NOW 2024: Investing to Eradicate Poverty and Expand Energy Access in Africa
00:10:00
Tailoring Investments to Personal Beliefs and Preferences
00:10:00
Artificial Intelligence (AI), Security, Internet of Things (IoT) and emerging Computational Biotech, Quantum Computing|Ashot Arzumanyan,Partner,SmartGateVC
00:10:00
Understanding Bonds: Coupon, Current Yield, and Yield to Maturity Explained | Charity DiCola - FIXED INCOME ANALYST of Howe & Rusling, Inc.
00:10:00
Biotech CEO discusses advancements in Alzheimer's and psychiatric disorder treatments, highlighting promising clinical results and future prospects |Stephan Jackman, CEO, Alzamend Neuro Inc.
00:10:00
September 8th, 2022 Investment Review & Outlook: Exploring International Investing Trends